查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827194

持续性週边神经阻断导管市场（按类型、引导技术、最终用户和应用）—全球预测 2025-2032

Continuous Peripheral Nerve Block Catheter Market by Type, Guidance Technology, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，持续性週边神经阻断导管市场将成长至 6.3601 亿美元，复合年增长率为 5.84%。

主要市场统计数据
基准年2024年 4.0361亿美元
预计2025年 4.2618亿美元
预测年份：2032年 6.3601亿美元
复合年增长率（%） 5.84%

权威介绍，描述影响现代护理途径中采用连续週边神经阻断导管的临床、操作和采购演变

持续性週边神经阻断导管已成为手术全期疼痛管理的支柱，提供标靶镇痛，减少全身性鸦片类药物依赖，促进患者康復。过去几年，临床医生和导管采购团队仔细审查了导管的特性，例如导管设计、与引导技术的兼容性以及是否易于融入多模式镇痛方案。这些因素改变了医疗机构评估和采用持续性神经阻断解决方案的方式，使其关注点从单一手术的效用转向更广泛的手术全期路径，强调缩短住院时间和改善功能恢復。

同时，临床实务也越来越青睐那些符合术后恢復原则和门诊手术照护模式的技术。这一趋势推动了人们对设备性能的新期望，包括稳定的阻滞效果、允许早期活动的安全固定方法以及最大程度缩短手术时间的使用者介面。因此，製造商和临床领导者正在建立更紧密的合作关係，以改善培训、标准化通讯协定并检验真实世界的结果，从而创造一个技术创新和临床证据共同影响购买和采用决策的环境。

因此，相关人员需要清晰的、基于证据的讯息，整合设备设计考量、引导技术影响以及最终用户的观点，为采购、临床医生教育和基于价值的采购策略提供指导。本报告旨在透过研究市场动态、临床应用模式以及将持续週边神经阻断导管纳入现代护理路径的实用建议，提供切实可行的资讯。

全面评估临床重点、影像引导的进步以及医疗保健服务的变化如何融合，以重新定义设备开发和采用的动态

由于临床重点、技术融合和医疗服务模式的转变，持续性週边神经阻断导管的市场格局正在发生重大变化。临床上，阿片类药物节约策略和增强型恢復通讯协定的趋势显着，凸显了可靠的局部麻醉技术的重要性。这些临床需求推动了对能够提供可预测镇痛、支持早期物理治疗并在适当情况下实现当天出院的设备的需求。

在技​​术方面，影像导引与导管设计的融合正在重塑手术工作流程。超音波引导已成为许多情况下的首选方法，它能够可视化神经结构和局部麻醉剂，并提高阻断的准确性和安全性。同时，製造商正在优化导管材质和固定係统，以降低移位和感染的风险，解决门诊和住院环境中遇到的重要实践障碍。这些技术进步与改进的培训工具和基于模拟的教育相辅相成，进一步提高了临床医生的能力并加速了技术的普及。

医疗保健服务运作模式的转变也影响着区域麻醉的采用轨迹。门诊手术中心和协作护理模式的成长，使得能够支援简化手术流程并在不同环境下实现一致疗效的设备成为重中之重。此外，不断发展的报销框架和品质指标，强调患者报告的疗效并减少阿片类药物相关不利事件，正在奖励医院和诊所优先考虑局部麻醉解决方案。总而言之，这些临床、技术和营运因素正在重新调整整个价值链的开发重点和商业策略。

简要分析2025年关税变化对营运和采购的影响，以及供应链调整如何重塑商业策略

2025年关税政策的出台，为医疗设备产业的采购、供应链管理和商业策略带来了新的复杂性。关税调整影响了製造、分销和采购管道的成本结构，迫使相关人员重新评估筹资策略和利润预期。对于依赖跨境供应链的製造商而言，这些变化促使他们重新审视供应商合约、零件本地化和库存缓衝，以降低风险敞口，增强对波动的进口关税的抵御能力。

医院和门诊中心正在透过收紧采购规范、延长竞标週期以及优先采购不仅具有临床价值而且总拥有成本可预测的设备来应对不断变化的成本驱动因素。在某些情况下，采购商正在探索其他供应商关係和合併采购协议，以抵消关税带来的额外成本。同时，小型专科诊所对价格波动更为敏感，要求临床医生评估其手术流程和设备利用率，以便在不影响临床品质的情况下，确保能够进行局部麻醉手术。

为了应对这一变化，製造商和经销商正在探索适应策略，例如将部分生产转移至近岸外包，重新设计包装以减轻关税的影响，以及提供以培训、保固和耗材管理为重点的配套服务模式。这些方法旨在保持竞争力，同时确保临床医生期望的临床表现和支援服务。因此，关税变化的净影响不仅体现在财务方面，也体现在营运方面，这迫使相关人员进行务实的调整，以维持临床可及性和长期的供应商伙伴关係。

综合分段分析说明导管类型、影像和引导方式、临床环境和程序应用如何共同决定采购和采用决策

细分洞察揭示了设备选择和临床部署如何因产品类型、引导技术、最终用户偏好和应用而异，从而形成不同的采用路径。在根据导管类型区分设备时，需要考虑的因素包括预期的手术用途以及临床医生对非刺激性导管（可简化插入）和刺激性导管（可在插入过程中提供神经定位反馈）的偏好。这种区别会影响训练要求和操作方案，因为在将电刺激确认神经接近度纳入临床实践的情况下，刺激性导管可能更受青睐。

引导技术进一步提升了临床工作流程和设备相容性。虽然在资源受限的环境中，盲法操作仍是主流，但神经刺激设备引导的方法可以透过确认运动反应来提高可靠性。相较之下，超音波引导正透过直接可视化解剖结构、提高阻滞精度并减少对二级立体定向方法的依赖，重新定义许多机构的实践标准。因此，有助于超音波可视化的设备功能，例如迴声导管设计和相容的插入套件，与优先考虑影像引导局部麻醉的团队产生了强烈共鸣。

最终使用者环境也会影响采购和使用模式。门诊手术中心优先考虑能够简化快速週转、减少阿片类药物相关併发症并实现当天出院的设备。医院通常会平衡更广泛的病例组合，并投资于临床医生培训和多学科路径，以支援整形外科和产科服务中持续进行的导管插入计画。专科诊所可能专注于特定手术的工作流程，并采用符合特定临床方案和患者吞吐量需求的设备。

应用为临床医生评估导管解决方案提供了终极视角。产科镇痛需要适用于剖腹产和分娩镇痛管理的设备和通讯协定，强调产妇活动能力和新生儿安全。整形外科手术对髋关节、膝关节和肩关节手术的需求各不相同，需要促进早期活动和復原的疼痛管理策略。手术室外的术后疼痛管理需要牢固的导管固定、感染控制措施以及清晰的门诊方案，以支持家庭镇痛。综合起来，这些细分观点凸显了为什么医疗设备组合和上市方案必须与临床工作流程和特定场所的优先事项紧密结合。

细緻入微的区域观点展示了美洲、欧洲、中东和非洲地区以及亚太地区在基础设施、报销和实践方面的差异如何影响设备采用和商业化策略

区域动态对设备选择、临床训练模式和分配策略有着强大的影响，这受到医疗基础设施、报销实践和临床实践模式差异的影响。在美洲，临床上强调加速復健、整形外科护理和产科护理，这促使人们对支持加速復健且安全的设备产生兴趣。都市区三级医疗中心着重先进影像和多学科路径的整合，而门诊机构则优先考虑能够最大程度缩短手术时间并支援当天出院的设备。

在欧洲、中东和非洲，医疗保健系统的差异导致了应用环境的差异。西欧资源丰富的医院普遍广泛采用超音波导引局部麻醉，并投资于基于模拟的临床医生培训和标准化通讯协定。相较之下，中东和非洲部分地区由于影像设备和训练有素的人员获取管道的差异，仍在使用替代引导策略，并且对设备成本和耐用性更为敏感。这一广大地区的分销网络和监管途径也各不相同，影响着製造商如何建构其市场准入和支援服务。

在亚太地区，手术量的快速增长和门诊能力的不断提升，推动了对高通量环境下可扩展解决方案的需求。与培训计画和学术中心的合作正在加速许多市场对影像引导手术的采用，而本地製造和供应结构往往会影响采购决策。在全部区域，相关人员正在应对全球临床趋势和特定地区的限制，促使製造商根据当地需求客製化其商业模式、教育推广和服务，同时保持一致的设备性能标准。

从策略上评估产品创新、临床医生教育和服务模式如何定义区域麻醉的竞争优势并影响采购选择

持续性週边神经阻断导管领域的竞争动态主要集中在产品创新、临床支援服务以及在实际应用中展现一致性能的能力。领先的製造商凭藉旨在降低移位和感染风险的导管材料和固定係统，以及简化无菌技术和超音波整合的配件套件，在竞争中脱颖而出。同样重要的是培训计画、模拟工具和临床伙伴关係，这些能够透过提高临床医生的信心和技术一致性来加速应用。

分销和服务模式也有助于提升竞争优势。提供整合设备、临床医生教育和上市后监测的捆绑式解决方案的公司，正日益受到寻求可预测结果和减轻营运负担的医院系统的青睐。与影像设备供应商、麻醉学会和学术中心的策略合作，可以提高知名度，并支持采用符合指南的实践。在医院重视服务连续性和快速设备补给的市场中，拥有敏捷供应链和本地化技术支援的供应商往往能够蓬勃发展。

最后，透过註册研究、观察性研究和实际临床合作等方式投入证据的公司，有助于检验真实世界的有效性，并为最佳实践提供参考。此类临床证据，加上强大的培训和服务生态系统，能够增强临床医生和采购委员会的信任，从而创造超越产品规格的可持续竞争优势。

为製造商和医疗保健领导者提供实用建议，使产品开发、临床医生培训和供应策略与现实世界的临床和营运重点保持一致

产业领导者可以果断采取行动，抓住临床和商业性机会，将研发重点与最终用户工作流程结合，并加强临床支援能力。优先考虑能够增强超音波可视化、安全固定和感染控制的导管功能，将解决临床医生最常提到的现实痛点。同时，投资扩充性的培训计划和模拟工具可以减少操作的差异性并加速应用，尤其是在要求操作人员一致性的医院和门诊中心。

在营运方面，製造商应考虑供应链策略，以降低关税波动的影响，并提高对区域需求波动的应对力。选用方案包括：选择性地将大批量生产外包，开发模组化包装以降低关税门槛，以及正式签订服务水准协议以确保及时补货。商业团队应强调捆绑式服务，将设备采购与临床医生培训、保固支援和数据收集选项相结合，以量化手术结果和患者体验。

从市场参与的角度来看，领导者应与整形外科和产科临床领导者建立伙伴关係，以产生真实世界证据并传播最佳实践通讯协定。针对门诊手术中心、医院和专科诊所量身订做价值提案，可以解决特定场景下的优先事项，例如吞吐量、復健时间表和门诊导管管理。透过整合临床、营运和商业性倡议，产业参与者可以打造引人注目的差异化产品，支援在各种医疗环境中永续应用。

一种透明的调查方法，解释瞭如何将临床医生访谈、临床指导综合和比较产品分析结合起来，产生可行的见解

本研究整合了同行评审的临床文献、操作指南以及对麻醉师、手术全期护理师和采购专业人员的初步定性访谈，旨在全面了解器械应用的驱动因素和障碍。调查方法强调临床实务洞察、产品特性评估和分销管道分析之间的三角关係，以确保结论既能反映实证医学，又能反映日常营运的实际情况。

原始资料收集包括结构化访谈和主题分析，以了解临床医生对导管类型、引导技术和门诊管理的偏好。二级资讯来源包括近期的程序指南，其中介绍了感染预防和导管固定的最佳实践，以及有关设备安全性的信息。在整个过程中，我们注意捕捉门诊中心、医院和专科诊所之间的差异，以确保研究结果适用于主要的最终使用者环境。

此分析方法透过比较设备组合和区域市场动态，将定性综合与特征映射结合。透过情境分析评估了供应链和政策影响，该分析考虑了常见的采购回应和製造商的缓解措施。结果优先考虑可操作的洞察而非抽象的模型，并提供了营运和临床领导者可以实施的建议，以优化采用率和患者疗效。

简洁、前瞻性的结论整合了临床重点、操作现实和支持有效采用持续週边神经阻断导管的协作策略

总而言之，持续性週边神经阻断导管在现代疼痛管理策略中发挥着至关重要的作用，其应用受到临床需求、影像技术进步和医疗服务模式演变等因素的影响。支援超音波整合、安全固定和门诊管理的设备特性始终与门诊手术中心、医院和专科诊所相关人员的优先事项保持一致。同时，持续投资临床医生培训和证据产生仍然是维持应用和提高操作一致性的关键。

包括供应链韧性和政策变化在内的商业力量要求製造商和采购团队协同应对，以维持患者可及性并维护基于价值的医疗目标。将产品创新与强大的培训、服务支援和自适应供应策略相结合的製造商将最有能力满足多样化医疗环境的复杂需求。最终，临床领导者、产业伙伴和机构负责人之间的持续合作将决定持续週边神经阻断导管在促进病患復原的同时，如何有效地实现品质和效率目标。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 导管材料创新，采用抗菌涂层，最大程度降低长期週边神经阻断使用过程中的感染风险
  • 人们对超音波导引週边神经阻断导管的需求日益增长，以提高整形外科手术的准确性和安全性。
  • 越来越多地采用整合智慧型手机导管控制的数位输液泵，以增强病患监测
  • 持续性神经阻断导管中缓释性局部麻醉剂剂的出现延长了镇痛时间并减少了鸦片类药物的消费量。
  • 开发门诊输液系统，使门诊病人能够持续进行週边神经阻断治疗并加速康復
  • 生物可吸收导管技术的进步使得止痛药给药后导管自行降解
  • 采用即时压力感测导管检测导管移位和阻断失败
  • 开发可同时输注镇痛药和抗发炎药物的多腔导管
  • 加强麻醉科和整形外科之间的合作，以标准化连续神经阻断通讯协定
  • 扩大持续性週边神经阻断导管安全和品质标准的法规结构

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 持续性週边神经阻断导管市场（按类型）

  • 无刺激性导管
  • 刺激导管

9.持续性週边神经阻断导管市场引导技术

  • 盲法
  • 神经刺激诱导
  • 超音波引导

第 10 章。 持续性週边神经阻断导管市场（依最终用户）

  • 门诊手术中心
  • 医院
  • 专科诊所

第11章。 连续週边神经阻断导管市场（依应用）

  • 产科镇痛
    • 剖腹产
    • 分娩疼痛管理
  • 整形外科
    • 髋关节置换术
    • 膝关节关节重建
    • 肩部手术
  • 术后疼痛管理

12. 持续性週边神经阻断导管市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 持续性週边神经阻断导管市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 持续性週边神经阻断导管市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Avanos Medical, Inc.
    • B. Braun Melsungen AG
    • Dyna Medical Corporation
    • Epimed International Inc.
    • ICU Medical, Inc.
    • Lepu Medical Technology（Beijing）Co., Ltd.
    • Medline Industries, LP
    • Medtronic plc
    • Merit Medical Systems, Inc.
    • Nipro Corporation
    • Owens & Minor, Inc.
    • PAJUNK GmbH Medizintechnologie
    • Poly Medicure Ltd.
    • Shunmei
    • Teleflex Incorporated
    • Vygon SA
Product Code: MRR-976C0ED91CFF

The Continuous Peripheral Nerve Block Catheter Market is projected to grow by USD 636.01 million at a CAGR of 5.84% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 403.61 million
Estimated Year [2025] USD 426.18 million
Forecast Year [2032] USD 636.01 million
CAGR (%) 5.84%

An authoritative introduction describing the evolving clinical, operational, and procurement drivers shaping continuous peripheral nerve block catheter adoption in modern care pathways

Continuous peripheral nerve block catheters have become a focal point in perioperative pain management, offering targeted analgesia that reduces systemic opioid reliance and enhances patient recovery. Over recent years, clinicians and procurement teams alike have scrutinized device characteristics such as catheter design, guidance technology compatibility, and ease of integration into multimodal analgesia protocols. These factors have driven an evolution in how healthcare organizations evaluate and adopt continuous nerve block solutions, with attention shifting from single-procedure utility toward broader perioperative pathways that emphasize reduced length of stay and improved functional recovery.

In parallel, clinical practice has increasingly favored technologies that align with enhanced recovery after surgery principles and ambulatory surgical care models. This trend has raised new expectations for device performance, including consistent block efficacy, secure fixation methods that permit early mobilization, and user interfaces that minimize procedure time. As a result, manufacturers and clinical leaders are forging closer collaborations to refine training, standardize protocols, and validate real-world outcomes, creating an environment where technological innovation and clinical evidence jointly influence purchasing and adoption decisions.

Consequently, stakeholders require clear, evidence-driven intelligence that synthesizes device design considerations, guidance technology implications, and end-user perspectives to inform procurement, clinician education, and value-based purchasing strategies. This report seeks to deliver that actionable intelligence by examining market dynamics, clinical adoption patterns, and practical recommendations for integrating continuous peripheral nerve block catheters into contemporary care pathways.

A comprehensive assessment of how clinical priorities, imaging guidance advances, and care delivery changes are converging to redefine device development and adoption dynamics

The landscape for continuous peripheral nerve block catheters is undergoing transformative shifts driven by clinical priorities, technology convergence, and changes in care delivery. Clinically, there is a pronounced move toward opioid-sparing strategies and enhanced recovery protocols, which elevates the importance of reliable regional anesthesia techniques. This clinical imperative has amplified demand for devices that deliver predictable analgesia while enabling early physiotherapy and same-day discharge where appropriate.

Technologically, the convergence of imaging guidance and catheter design is reshaping procedural workflows. Ultrasound guidance has emerged as a preferred modality in many settings because it improves visualization of nerve structures and local anesthetic spread, thereby enhancing block accuracy and safety. Simultaneously, manufacturers are optimizing catheter materials and fixation systems to reduce dislodgement and infection risk, which addresses key practical barriers encountered in ambulatory and inpatient environments. These technological advancements are complemented by improved training tools and simulation-based education that accelerate clinician competency and adoption.

Operational shifts in healthcare delivery also influence the trajectory of adoption. The growth of ambulatory surgical centers and shared-care models places a premium on devices that support streamlined procedures and consistent outcomes across disparate settings. In addition, evolving reimbursement frameworks and quality metrics emphasize patient-reported outcomes and reductions in opioid-related adverse events, creating incentives for hospitals and clinics to prioritize regional anesthesia solutions. Taken together, these clinical, technological, and operational forces are redirecting development priorities and commercial strategies across the value chain.

An analytical overview of the operational and procurement implications stemming from 2025 tariff changes and how supply chain adjustments are reshaping commercial strategies

The introduction of tariff policies in 2025 has introduced a new layer of complexity for procurement, supply chain management, and commercial strategy within the medical device sector. Tariff adjustments influence cost structures across manufacturing, distribution, and procurement channels, requiring stakeholders to reassess sourcing strategies and margin expectations. For manufacturers that rely on cross-border supply chains, these changes have triggered a review of supplier contracts, component localization, and inventory buffers to mitigate exposure to variable import duties and broaden resilience.

Hospitals and ambulatory centers respond to altered cost dynamics by tightening procurement specifications, extending tender cycles, and prioritizing devices that demonstrate not only clinical value but also predictable total cost of ownership. In some cases, purchasers explore alternative supplier relationships or consolidated purchasing agreements to offset additional tariff-induced costs. Meanwhile, smaller specialty clinics may face greater sensitivity to price changes, prompting clinicians to evaluate procedural workflows and device utilization to preserve access to regional anesthesia techniques without eroding clinical quality.

In response, manufacturers and distributors are exploring adaptive strategies such as nearshoring select production, redesigning packaging to reduce tariff exposure, and offering bundled service models that emphasize training, warranty, and consumable management. These approaches aim to preserve competitiveness while maintaining the clinical performance and support services that clinicians expect. The net effect of tariff changes is therefore not only financial but operational, compelling stakeholders to pursue pragmatic adjustments that sustain clinical access and long-term supplier partnerships.

An integrated segmentation analysis explaining how catheter type, imaging and guidance methods, clinical setting, and procedural application jointly determine procurement and adoption decisions

Insight into segmentation reveals how device selection and clinical deployment vary across product type, guidance technology, end-user setting, and application, each shaping distinct adoption pathways. When devices are differentiated by catheter type, considerations center on the intended procedural use and clinician preference for either nonstimulating catheters that simplify insertion or stimulating catheters that provide nerve localization feedback during placement. This distinction influences training requirements and procedural protocols because stimulating catheters may be favored in settings where electrical confirmation of nerve proximity is integrated into clinical practice.

Guidance technology further stratifies clinical workflows and device compatibility. Blind techniques continue to persist in certain resource-constrained environments, but nerve stimulator-guided approaches offer incremental confidence through motor response confirmation. Ultrasound guidance, by contrast, has redefined standards of practice in many centers by providing direct visualization of anatomy, which improves block accuracy and reduces reliance on secondary localization methods. As a result, device features that facilitate ultrasound visualization, such as echogenic catheter design and compatible insertion kits, resonate strongly with teams prioritizing image-guided regional anesthesia.

End-user environments also affect procurement and utilization patterns. Ambulatory surgical centers prioritize rapid turnover, minimal opioid-related complications, and devices that streamline same-day discharge. Hospitals often balance a broader case mix and invest in clinician training and multidisciplinary pathways that support continuous catheter programs across orthopedic and obstetric services. Specialty clinics concentrate on procedure-specific workflows and may adopt devices that align with focused clinical protocols and patient throughput demands.

Applications provide a final lens through which clinicians assess catheter solutions. Obstetric analgesia requires devices and protocols suited for both cesarean delivery and labor pain management, with emphasis on maternal mobility and neonatal safety. Orthopedic surgery presents diverse needs across hip, knee, and shoulder procedures, with pain control strategies that facilitate early mobilization and rehabilitation. Postoperative pain management beyond the operating theater demands secure catheter fixation, infection prevention measures, and clear outpatient protocols to support home-based analgesia when indicated. Taken together, these segmentation perspectives reveal why device portfolios and go-to-market approaches must align tightly with clinical workflows and setting-specific priorities.

A nuanced regional perspective illustrating how infrastructure, reimbursement, and practice variation across the Americas, EMEA, and Asia-Pacific influence device adoption and commercialization strategies

Regional dynamics exert a powerful influence on device selection, clinical training models, and distribution strategies, shaped by differences in healthcare infrastructure, reimbursement practices, and clinical practice patterns. In the Americas, clinical emphasis on enhanced recovery, orthopedic volume, and obstetric services drives interest in devices that support accelerated rehabilitation and strong safety profiles. Urban tertiary centers emphasize advanced imaging integration and multidisciplinary pathways, while ambulatory sites prioritize devices that minimize procedure time and support same-day discharge.

Across Europe, the Middle East, and Africa, heterogeneity in healthcare systems creates diverse adoption environments. High-resource hospitals in Western Europe typically adopt ultrasound-guided regional anesthesia widely, investing in simulation-based clinician training and standardized protocols. Meanwhile, in some parts of the Middle East and Africa, variability in access to imaging equipment and trained personnel leads to continued use of alternative guidance strategies and greater sensitivity to device cost and durability. Distribution networks and regulatory pathways also differ across this broad region, influencing how manufacturers structure market entry and support services.

In the Asia-Pacific region, rapid growth of surgical volumes and expanding ambulatory care capacity drive demand for solutions that can scale across high-throughput settings. Training programs and partnerships with academic centers accelerate adoption of image-guided techniques in many markets, while localized manufacturing and supply arrangements often influence procurement decisions. Across these regions, stakeholders respond to both global clinical trends and region-specific constraints, prompting manufacturers to tailor commercial models, educational outreach, and service offerings to local needs while maintaining consistent device performance standards.

A strategic evaluation of how product innovation, clinician education, and service models converge to define competitive advantage and influence procurement choices in regional anesthesia

Competitive dynamics in the continuous peripheral nerve block catheter space center on product innovation, clinical support services, and the ability to demonstrate consistent performance in real-world settings. Leading manufacturers differentiate through catheter materials and fixation systems designed to reduce dislodgement and infection risk, as well as through accessory kits that simplify sterile technique and ultrasound integration. Equally important are training programs, simulation tools, and clinical partnerships that accelerate adoption by improving clinician confidence and procedural consistency.

Distribution and service models also underpin competitive positioning. Firms that offer bundled solutions combining devices, clinician education, and post-market surveillance gain traction with hospital systems seeking predictable outcomes and reduced operational burden. Strategic collaborations with imaging equipment providers, anesthesiology societies, and academic centers amplify visibility and support guideline-aligned practice adoption. Vendors that maintain responsive supply chains and localized technical support tend to perform better in markets where hospitals prioritize service continuity and rapid device replenishment.

Finally, companies that invest in evidence generation through registries, observational studies, and pragmatic clinical collaborations help to validate real-world effectiveness and inform best practices. This clinical evidence, when paired with robust training and service ecosystems, reinforces trust among clinician champions and purchasing committees, creating a durable competitive advantage that extends beyond product specifications alone.

Actionable recommendations for manufacturers and healthcare leaders to align product development, clinician training, and supply strategies with real-world clinical and operational priorities

Industry leaders can act decisively to capture clinical and commercial opportunities by aligning R&D priorities with end-user workflows and by strengthening clinical support capabilities. Prioritizing catheter features that enhance ultrasound visualization, secure fixation, and infection control will address the practical pain points most commonly cited by clinicians. In parallel, investing in scalable training programs and simulation tools will reduce variability in technique and accelerate adoption, particularly in hospitals and ambulatory centers seeking operator consistency.

Operationally, manufacturers should consider supply chain strategies that reduce exposure to tariff variability and improve responsiveness to regional demand fluctuations. Options include selectively nearshoring high-volume production, developing modular packaging to mitigate tariff thresholds, and formalizing service-level agreements that assure timely replenishment. Commercial teams should emphasize bundled offerings that link device procurement with clinician education, warranty support, and data collection options to quantify procedural outcomes and patient experience.

From a market engagement perspective, leaders should cultivate partnerships with orthopedic and obstetric clinical champions to generate real-world evidence and disseminate best-practice protocols. Tailored value propositions for ambulatory surgical centers, hospitals, and specialty clinics will help address setting-specific priorities such as throughput, rehabilitation timelines, and outpatient catheter management. By integrating clinical, operational, and commercial initiatives, industry players can create compelling, differentiated offerings that support sustainable adoption across diverse care settings.

A transparent research methodology describing how primary clinician interviews, clinical guidance synthesis, and comparative product analysis were integrated to produce actionable insights

This research synthesizes peer-reviewed clinical literature, procedural guidelines, and primary qualitative interviews with anesthesiologists, perioperative nurses, and procurement specialists to develop a comprehensive understanding of device adoption drivers and barriers. The methodology emphasizes triangulation between clinical practice insights, product feature evaluations, and distribution channel analysis to ensure that conclusions reflect both evidence-based medicine and day-to-day operational realities.

Primary data collection included structured interviews and thematic analysis designed to capture clinician preferences around catheter type, guidance technology, and outpatient management. Secondary sources included recent procedural guidelines and device safety communications that inform best practices for infection prevention and catheter fixation. Throughout the process, attention focused on capturing heterogeneity across ambulatory centers, hospitals, and specialty clinics to ensure findings remain applicable across the primary end-user environments.

Analytical methods combined qualitative synthesis with comparative feature mapping across device portfolios and regional market dynamics. Supply chain and policy impacts were assessed through scenario analysis that considered common procurement responses and manufacturer mitigations. The resulting approach prioritizes actionable insight over abstract modeling, delivering recommendations that operational and clinical leaders can implement to optimize adoption and patient outcomes.

A concise and forward-looking conclusion that synthesizes clinical priorities, operational realities, and collaborative strategies underpinning effective adoption of continuous peripheral nerve block catheters

In conclusion, continuous peripheral nerve block catheters occupy a pivotal role in contemporary pain management strategies, with adoption shaped by a confluence of clinical imperatives, imaging technology advances, and evolving care delivery models. Device characteristics that support ultrasound integration, secure fixation, and outpatient management consistently align with stakeholder priorities across ambulatory surgical centers, hospitals, and specialty clinics. Meanwhile, ongoing investments in clinician training and evidence generation remain central to sustaining adoption and improving procedural consistency.

Operational forces, including supply chain resilience and policy shifts, require coordinated responses from manufacturers and procurement teams to preserve access and maintain value-based care objectives. Manufacturers that couple product innovation with robust training, service support, and adaptive supply strategies will be best positioned to meet the complex needs of diverse healthcare settings. Ultimately, sustained collaboration between clinical leaders, industry partners, and institutional purchasers will determine how effectively continuous peripheral nerve block catheters enhance patient recovery while advancing quality and efficiency objectives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Innovation in catheter materials with antimicrobial coatings to minimize infection risk in prolonged peripheral nerve block use
  • 5.2. Rising demand for ultrasound-guided peripheral nerve block catheters to improve procedural accuracy and safety in orthopedic surgeries
  • 5.3. Increasing adoption of digital infusion pumps integrated with smartphone-enabled catheter control for enhanced patient monitoring
  • 5.4. Emergence of extended-release local anesthetic formulations in continuous nerve block catheters to prolong analgesia and reduce opioid consumption
  • 5.5. Development of ambulatory infusion systems enabling outpatient continuous peripheral nerve block therapy for accelerated rehabilitation
  • 5.6. Advances in bioresorbable catheter technology for automatic degradation after analgesia delivery
  • 5.7. Adoption of real-time pressure-sensing catheters to detect catheter migration or block failure
  • 5.8. Development of multi-lumen catheters enabling simultaneous infusion of analgesic and anti-inflammatory agents
  • 5.9. Increasing collaboration between anesthesiology and orthopedics to standardize continuous nerve block protocols
  • 5.10. Expansion of regulatory frameworks for continuous peripheral nerve block catheter safety and quality standards

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Continuous Peripheral Nerve Block Catheter Market, by Type

  • 8.1. Non Stimulating Catheter
  • 8.2. Stimulating Catheter

9. Continuous Peripheral Nerve Block Catheter Market, by Guidance Technology

  • 9.1. Blind Technique
  • 9.2. Nerve Stimulator Guided
  • 9.3. Ultrasound Guided

10. Continuous Peripheral Nerve Block Catheter Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Specialty Clinics

11. Continuous Peripheral Nerve Block Catheter Market, by Application

  • 11.1. Obstetric Analgesia
    • 11.1.1. C Section
    • 11.1.2. Labor Pain Management
  • 11.2. Orthopedic Surgery
    • 11.2.1. Hip Replacement
    • 11.2.2. Knee Replacement
    • 11.2.3. Shoulder Surgery
  • 11.3. Postoperative Pain Management

12. Continuous Peripheral Nerve Block Catheter Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Continuous Peripheral Nerve Block Catheter Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Continuous Peripheral Nerve Block Catheter Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Avanos Medical, Inc.
    • 15.3.2. B. Braun Melsungen AG
    • 15.3.3. Dyna Medical Corporation
    • 15.3.4. Epimed International Inc.
    • 15.3.5. ICU Medical, Inc.
    • 15.3.6. Lepu Medical Technology (Beijing) Co., Ltd.
    • 15.3.7. Medline Industries, LP
    • 15.3.8. Medtronic plc
    • 15.3.9. Merit Medical Systems, Inc.
    • 15.3.10. Nipro Corporation
    • 15.3.11. Owens & Minor, Inc.
    • 15.3.12. PAJUNK GmbH Medizintechnologie
    • 15.3.13. Poly Medicure Ltd.
    • 15.3.14. Shunmei
    • 15.3.15. Teleflex Incorporated
    • 15.3.16. Vygon SA

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 134. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 138. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 148. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 154. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 196. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 204. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 205. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 210. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 240. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 243. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 254. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 255. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 256. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)

TABLE 2